Related Experiment Video
Updated: Jun 7, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro
Dongfei Liu1, Yifan Ge, Yue Tang
1School of Pharmacy, Nanjing Medical University, Nanjing 210029, People's Republic of China.
Abstract:
The aim of this study was to prepare diclofenac sodium (DNa) solid lipid nanoparticles (SLNs) by a modified emulsion/solvent evaporation method for transdermal delivery. Five independent processing parameters including the lipid matrix, emulsifiers, co-emulsifiers, water-dispersed phase and organic phase were assessed systematically to enhance the entrapment of DNa. The SLNs produced by optimal formulation were submicrometre size with low polydispersity index, the entrapment efficiency was about 89% and the drug loading was about 9.5%. Shape and surface morphology were determined by transmission electron microscopy, which revealed the fairly spherical and core-shell shapes of the SLNs. The in vitro release of SLNs showed a two-step release pattern: one initial burst release followed by a second slow-release phase. In the in vitro cutaneous permeation studies, value of flux obtained for DNa solution was higher than that of SLNs suspension. SLNs had also been shown to improve the dermal localization of DNa.
Related Concept Videos
Transdermal Drug Delivery Systems
Oral Drug Delivery Systems: Delayed-Release Systems
Bioavailability Enhancement: Drug Permeability Enhancement
Factors Affecting Dissolution: Particle Size and Effective Surface Area
In Vitro Drug Dissolution: Alternative Methods

